Generic tracker
GLP-1 generic tracker for Canada
What Health Canada has authorized, what is on the market, and which generic lots were recalled. Source: the Drug Product Database of Health Canada.
Key facts
The Drug Product Database of Health Canada shows 2 generic products with the status Marketed.
It shows 4 more generic products with an approval that are not on the market yet.
Health Canada posted 4 recalls of generic lots.
Generic semaglutide products
A product with the status Approved has an authorization. A product with the status Marketed is for sale in Canada.
Brand semaglutide products
The products of the company that first made the medication.
Brand liraglutide products
The products of the company that first made the medication.
Brand tirzepatide products
The products of the company that first made the medication.
Recalls of generic lots
Where this comes from
Each row comes from the Drug Product Database of Health Canada, read on 2026-11-12. A row is one product name with one status. A product can have a DIN for each strength.
The recalls come from the recalls site of the Government of Canada. The date is the date of the last update of the notice.
Ask a pharmacist before you change a medication.